Sino Medical Sciences Technology Inc.

Shanghai Stock Exchange 688108.SS

Sino Medical Sciences Technology Inc. Cash and Short-Term Investments for the year ending December 31, 2023: USD 26.57 M

Sino Medical Sciences Technology Inc. Cash and Short-Term Investments is USD 26.57 M for the year ending December 31, 2023, a -9.87% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Sino Medical Sciences Technology Inc. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 29.48 M, a -34.91% change year over year.
Sino Medical Sciences Technology Inc. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 45.29 M, a -45.73% change year over year.
Sino Medical Sciences Technology Inc. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 83.44 M, a -8.98% change year over year.
Sino Medical Sciences Technology Inc. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 91.67 M, a 68.12% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 688108.SS

Sino Medical Sciences Technology Inc.

CEO	Mr. Jianhua Sun
IPO Date	Oct. 30, 2019
Location	China
Headquarters	TEDA Biopharm Res, Building B
Employees	652
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Clinical Trials Pharmaceuticals

Description

Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional devices in China. Its products include drug-eluting stents, balloon catheters, coronary stents, and transcatheter mitral valve replacement devices. Sino Medical Sciences Technology Inc. has a clinical collaboration agreement with The National University of Ireland Galway. The company was founded in 2007 and is headquartered in Tianjin, China.

Key trends

Past 5 years